BRIEF-FDA Accepts Turnstone Biologics’ IND For Cancer Immunotherapy – Reuters
|
BRIEF-FDA Accepts Turnstone Biologics' IND For Cancer Immunotherapy
Reuters May 16 (Reuters) – Turnstone Biologics: * TURNSTONE BIOLOGICS ANNOUNCES U.S. FDA ACCEPTANCE OF IND FOR IMMUNOTHERAPY TARGETING HPV POSITIVE CANCERS. * TURNSTONE BIOLOGICS ANNOUNCES U.S. FDA ACCEPTANCE OF … |
